Pharmaids [PHARMAID] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison
Pharmaids
BSE
Loading...
Sun Pharma Advanced
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Pharmaids wins in 9 metrics, Sun Pharma Advanced wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Pharmaids | Sun Pharma Advanced | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2,023.33 | -13.85 | Sun Pharma Advanced |
| Price-to-Book Ratio | 3.71 | -21.83 | Sun Pharma Advanced |
| Debt-to-Equity Ratio | 70.81 | -1.24 | Sun Pharma Advanced |
| PEG Ratio | 23.66 | 0.30 | Sun Pharma Advanced |
| EV/EBITDA | -17.36 | -17.66 | Sun Pharma Advanced |
| Profit Margin (TTM) | -61.01% | -53.22% | Sun Pharma Advanced |
| Operating Margin (TTM) | -90.28% | -568.05% | Pharmaids |
| Return on Equity | -19.58% | 157.88% | Sun Pharma Advanced |
| Return on Assets (TTM) | -8.99% | -102.08% | Pharmaids |
| Free Cash Flow (TTM) | $-264.72M | $-3.71B | Pharmaids |
| 1-Year Return | 42.56% | -34.43% | Pharmaids |
| Price-to-Sales Ratio (TTM) | 10.23 | 73.39 | Pharmaids |
| Enterprise Value | $2.51B | $50.08B | Sun Pharma Advanced |
| EV/Revenue Ratio | 11.75 | 77.52 | Pharmaids |
| Gross Profit Margin (TTM) | 47.39% | -10.68% | Pharmaids |
| Revenue per Share (TTM) | $6 | $2 | Pharmaids |
| Earnings per Share (Diluted) | $-3.70 | $-9.19 | Pharmaids |
| Beta (Stock Volatility) | 0.38 | 0.31 | Sun Pharma Advanced |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Pharmaids vs Sun Pharma Advanced Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pharmaids | -0.43% | -0.58% | -7.46% | -8.45% | -12.03% | -16.22% |
| Sun Pharma Advanced | 0.71% | 1.72% | -7.23% | -10.11% | 14.74% | -27.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pharmaids | 42.56% | 369.70% | 1,702.33% | 1,893.57% | 1,477.61% | 167.24% |
| Sun Pharma Advanced | -34.43% | -37.13% | -23.18% | -60.88% | 58.71% | -49.74% |
Performance & Financial Health Analysis: Pharmaids vs Sun Pharma Advanced
| Metric | PHARMAID | SPARC |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.19B | ₹47.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,939 | 250,949 |
| 90 Day Avg. Volume | 9,637 | 349,451 |
| Last Close | ₹62.00 | ₹146.08 |
| 52 Week Range | ₹31.90 - ₹87.46 | ₹109.30 - ₹241.00 |
| % from 52W High | -29.11% | -39.39% |
| All-Time High | ₹87.46 (Nov 11, 2024) | ₹875.00 (Apr 24, 2006) |
| % from All-Time High | -29.11% | -83.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.43% | -0.43% |
| Quarterly Earnings Growth | 0.43% | -0.43% |
| Financial Health | ||
| Profit Margin (TTM) | -0.61% | -0.53% |
| Operating Margin (TTM) | -0.90% | -5.68% |
| Return on Equity (TTM) | -0.20% | 1.58% |
| Debt to Equity (MRQ) | 70.81 | -1.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹16.72 | ₹-6.69 |
| Cash per Share (MRQ) | ₹0.61 | ₹0.06 |
| Operating Cash Flow (TTM) | ₹-278,094,000 | ₹-3,484,287,000 |
| Levered Free Cash Flow (TTM) | ₹-107,766,000 | ₹-3,425,094,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Pharmaids vs Sun Pharma Advanced
| Metric | PHARMAID | SPARC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2,023.33 | -13.85 |
| Forward P/E | N/A | 2.64 |
| PEG Ratio | 23.66 | 0.30 |
| Price to Sales (TTM) | 10.23 | 73.39 |
| Price to Book (MRQ) | 3.71 | -21.83 |
| Market Capitalization | ||
| Market Capitalization | ₹2.19B | ₹47.41B |
| Enterprise Value | ₹2.51B | ₹50.08B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.75 | 77.52 |
| Enterprise to EBITDA | -17.36 | -17.66 |
| Risk & Other Metrics | ||
| Beta | 0.38 | 0.31 |
| Book Value per Share (MRQ) | ₹16.72 | ₹-6.69 |
Financial Statements Comparison: Pharmaids vs Sun Pharma Advanced
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PHARMAID | SPARC |
|---|---|---|
| Revenue/Sales | ₹66.64M | ₹96.40M |
| Cost of Goods Sold | ₹35.06M | ₹106.70M |
| Gross Profit | ₹31.58M | ₹-10.30M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-60.16M | ₹-547.60M |
| EBITDA | ₹-53.69M | ₹-429.40M |
| Pre-Tax Income | ₹-71.71M | ₹-518.10M |
| Income Tax | ₹-18.56M | ₹600,000 |
| Net Income (Profit) | ₹-53.15M | ₹-518.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PHARMAID | SPARC |
|---|---|---|
| Cash & Equivalents | ₹21.45M | ₹19.64M |
| Total Current Assets | ₹223.07M | ₹261.97M |
| Total Current Liabilities | ₹287.15M | ₹3.74B |
| Long-Term Debt | ₹331.19M | ₹1.07B |
| Total Shareholders Equity | ₹550.42M | ₹-2.17B |
| Retained Earnings | N/A | ₹-23.22B |
| Property, Plant & Equipment | ₹446.50M | ₹178.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PHARMAID | SPARC |
|---|---|---|
| Operating Cash Flow | ₹-1.10M | N/A |
| Capital Expenditures | ₹0 | N/A |
| Free Cash Flow | ₹2.39M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PHARMAID | SPARC |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,939 | 250,949 |
| Average Daily Volume (90 Day) | 9,637 | 349,451 |
| Shares Outstanding | 35.27M | 324.52M |
| Float Shares | 5.46M | 91.74M |
| % Held by Insiders | 0.93% | 0.73% |
| % Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Pharmaids vs Sun Pharma Advanced
| Metric | PHARMAID | SPARC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |